EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment

Maik Luu iD, Burkhard Schütz iD, Matthias Lauth, Alexander Visekruna iD

Cancers · 03.03.2023 · 15 (5) · 1588

DOI: 10.3390/cancers15051588 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 03.03.2023. Verfasst von Maik Luu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, DFG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prevention of the effectiveness of anti-tumor immune responses is one of the canonical cancer hallmarks. The competition for crucial nutrients within the tumor microenvironment (TME) between cancer cells and immune cells creates a complex interplay characterized by metabolic deprivation. Extensive efforts have recently been made to understand better the dynamic interactions between cancer cells and surrounding immune cells. Paradoxically, both cancer cells and activated T cells are metabolically dependent on glycolysis, even in the presence of oxygen, a metabolic process known as the Warburg effect. The intestinal microbial community delivers various types of small molecules that can potentially augment the functional capabilities of the host immune system. Currently, several studies are trying to explore the complex functional relationship between the metabolites secreted by the human microbiome and anti-tumor immunity. Recently, it has been shown that a diverse array of commensal bacteria synthetizes bioactive molecules that enhance the efficacy of cancer immunotherapy, including immune checkpoint inhibitor (ICI) treatment and adoptive cell therapy with chimeric antigen receptor (CAR) T cells. In this review, we highlight the importance of commensal bacteria, particularly of the gut microbiota-derived metabolites that are capable of shaping metabolic, transcriptional and epigenetic processes within the TME in a therapeutically meaningful way.

Schlagwörter

Stichwörter der Autor:innen

cancer immunotherapycommensal bacteriaintratumoral microbiotamicrobiota-derived metabolitesoncobiometumor microenvironment (TME)

Autor:innen und Institutionen

  • Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany.
  • Institute of Anatomy and Cell Biology, Philipps-University Marburg, 35037 Marburg, Germany.
  • Department of Gastroenterology, Center for Tumor and Immune Biology (ZTI), Philipps-University Marburg, 35043 Marburg, Germany.
  • Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, 35043 Marburg, Germany.

ORCID-Profile: Maik Luu, Burkhard Schütz, Alexander Visekruna

Förderung

  • Deutsche Forschungsgemeinschaft
  • DFG

Zitieren

APA

Luu, M., Schütz, B., Lauth, M., & Visekruna, A. (2023). The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment. Cancers, 15(5), 1588. https://doi.org/10.3390/cancers15051588

Vancouver

Luu M, Schütz B, Lauth M, Visekruna A. The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment. Cancers. 2023;15(5):1588. doi:10.3390/cancers15051588

BibTeX
@article{Luu2023,
  author = {Luu, Maik and Schütz, Burkhard and Lauth, Matthias and Visekruna, Alexander},
  title = {The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {1588},
  doi = {10.3390/cancers15051588}
}
Kostenlos starten →